Takahiro Ebata

655 citations
34 papers · 404 indexed · h-index 12
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Ovarian cancer diagnosis and treatment (6 papers)Renal cell carcinoma treatment (4 papers)

In The Last Decade

Takahiro Ebata

34 papers receiving 397 citations

Peers

Takahiro Ebata
Comparison fields: 5 of 75
  • Oncology 160
  • Molecular Biology 152
  • Pulmonary and Respiratory Medicine 102
  • Cell Biology 57
  • Cancer Research 52
Replace Katsuya Matsuda with:
Katsuya Matsuda Japan
Wei Cang China
Ruoyan Liu China
Mika Wakabayashi Japan
Sung Sun Kim South Korea
Sumegha Mitra United States
Malee Warnnissorn Thailand
Qiao Xiong China
Shigenori Furukawa Japan
Isaiah G. Schauer United States
Takahiro Ebata relative to Katsuya Matsuda Japan Katsuya Matsuda's profile →
Citations per field
00.5×3.6×
Katsuya Matsuda · 1×
Citations per year

Countries citing papers authored by Takahiro Ebata

Since Specialization
Citations

This map shows the geographic impact of Takahiro Ebata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Ebata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Ebata more than expected).

Fields of papers citing papers by Takahiro Ebata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Ebata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Ebata. The network helps show where Takahiro Ebata may publish in the future.

Co-authorship network of co-authors of Takahiro Ebata

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Ebata. A scholar is included among the top collaborators of Takahiro Ebata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Ebata. Takahiro Ebata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 3
3 5
4 5
5 4
6 3
7 8
8 8
9 8
10 1
11 6
12 17
13 5
14 4
15 33
16 11
17 1
18 61
19 9
20 17

About Takahiro Ebata

Takahiro Ebata is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology, having authored 34 papers that have together received 404 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Oncology (160 citations), Biological Psychiatry (14 citations) and Reproductive Medicine (34 citations). Takahiro Ebata has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Keiko Kawauchi, Yuichi Takiguchi, Shunichiro Iwasawa, Koichiro Tatsumi, Tsukasa Ishiwata, Hiroaki Hirata, Ryota Kurimoto, Yuji Tada, Keigo Araki and Kenji Tamura. Their work appears in journals such as Annals of Oncology, Cellular and Molecular Life Sciences and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026